Current Neuro-Oncology

Volume 27 Number 27
30 September 2025

Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 27, 30 September

Ma H, Zeng S, Huang Y, Xie D, Mazu L, Zhu N, Zhao J, Yang Z, Chu J.
Predicting glioma histo-molecular diagnosis and prognosis: preoperative dynamic contrast-enhanced magnetic resonance imaging insights.
Quant Imaging Med Surg. 2025 Sep 22;15(10):9855-9870. doi: 10.21037/qims-2025-36. PMID: 41081223. Observational study. ˍ

Topiwala A, Levey DF, Zhou H, Deak JD, Adhikari K, Ebmeier KP, Bell S, Burgess S, Nichols TE, Gaziano M, Stein M, Gelernter J. Alcohol use and risk of dementia in diverse populations: evidence from cohort, case-control and Mendelian randomisation approaches.
BMJ Evid Based Med. 2025 Sep 23:bmjebm-2025-113913. doi: 10.1136/bmjebm-2025-113913. PMID: 40987604. Observational study. ˍ

She L, Wu H, Zhang X, Zheng C, Su L.
A retrospective analysis of survival prognostic factors and risk stratification in recurrent glioblastoma.
Ann Med. 2025 Sep 24;57(1):2533435. doi: 10.1080/07853890.2025.2533435. PMID: 40991008. Observational study. ˍ

Zhang J, Liu H, Wu Y, Zhu J, Wang Y, Zhou Y, Wang M, Sun Q, Che F, Li B.
Pilot research on predicting the sub-volume with high risk of tumor recurrence inside peritumoral edema using the ratio-maxiADC/meanADC from the advanced MRI.
Discov Oncol. 2025 Sep 24;16(1):1697. doi: 10.1007/s12672-025-03199-3. PMID: 40993281. Observational study. ˍ

Imai N, Yano H, Ikegame Y, Yasuda S, Morishima R, Ikuta S, Nakayama N, Maruyama T, Ohe N, Kumagai M, Muragaki Y, Shinoda J, Izumo T.
Evaluation of [¹¹C]-Methionine Positron Emission Tomography and Cerebral Blood Volume Imaging in the Diagnosis of Non-Contrast-Enhanced Gliomas.
J Clin Med. 2025 Sep 25;14(19):6777. doi: 10.3390/jcm14196777. PMID: 41095858. Observational study. ˍ

Tini P, Donnini F, Marampon F, Pastina P, Rubino G, Battaglia G, Chibbaro S, Cerase A, Mazzei MA, Desideri I, Minniti G.
Timing matters: overall treatment time, radiotherapy interruptions, and outcomes in glioblastomas-prognostic significance in different biological sub-groups.
J Neurooncol. 2025 Sep 25;175(3):1261-1269. doi: 10.1007/s11060-025-05215-6. PMID: 40996682. Observational study. ˍ

Wainwright D, Lukas R, Zhai L, Lauing K, Kim M, Koch T, Penco-Campillo M, Bommi P, Dixit K, Kumthekar P, Sharp L, Lezon R, Garcia D, Sonabend A, McCortney K, Castro B, Chandler J, Gondi V, Grimm S, Heimberger A, Dobinda K, Zhang H, Sachdev S, Juhasz C, James CD, Allen J, Horbinski C, Lesniak M, Stupp R, Miska J.
Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205.
Res Sq [Preprint]. 2025 Sep 25:rs.3.rs-7567487. doi: 10.21203/rs.3.rs-7567487/v1. PMID: 41041559. Interventional study. ˍ

Grkovski M, Daras M, Bale T, Lyashchenko S, Reiner AS, Mellinghoff IK, Schöder H, Dunphy MPS.
¹⁸F-BMS-986229 PET imaging of tumor PD-L1 expression in glioblastoma patients.
EJNMMI Res. 2025 Sep 26;15(1):124. doi: 10.1186/s13550-025-01283-x. PMID: 41003913. Interventional study. ˍ

Tang X, Wei W, Huang Y, Zheng Y, Xu Y, Li F.
A case report on IDH-mutant astrocytoma, CNS WHO grade 4: multi-omic characterization of untreated clinical progression.
Front Oncol. 2025 Sep 26;15:1557245. doi: 10.3389/fonc.2025.1557245. PMID: 41079096. Case report. ˍ

Moretti ME, Broggi M, Schiariti M, Restelli F, Barbieri EM, Fontanella MM, Maltoni D, Fioravanti A, Zoia C, Montalbetti A, Leonardi M, Camarda G, Soldini E, Maresca L, Mattioli L, Ciocca R, Boccardi E, Dimeco F, Ferroli P.
Evaluation Of Presurgical Outcome Predictors In Oncological Neurosurgery.
World Neurosurg. 2025 Sep 27:124518. doi: 10.1016/j.wneu.2025.124518. PMID: 41022312. Observational study. ˍ

Huang J, Johanns TM, Campian JL, Chicoine M, Zipfel G, Chheda M, Butt O, Ivanov D, Chernyshov K, Salem B, Tkachuk A, Frank A, Klimova D, Tabakov D, Harmanci AS, Chen WC, Patel AJ, Raleigh DR, Kim AH, Chen CK.
A phase I window-of-opportunity study of neoadjuvant avelumab and hypofractionated radiation therapy in radiation-relapsed meningioma.
medRxiv [Preprint]. 2025 Sep 28:2025.09.26.25336740. doi: 10.1101/2025.09.26.25336740. PMID: 41040714. Interventional study. ˍ

An X, Wang J, Yuan J, Zhou X, Liu X, Sun X, Gong J, Wu Q, Ou Y.
Prognostic value of temporal muscle thickness in pediatric medulloblastoma patients aged 3-12 years.
J Neurooncol. 2025 Sep 29;175(3):1235-1246. doi: 10.1007/s11060-025-05229-0. PMID: 41023500. Observational study˰ ˍ

Harding JJ, Oh DY, Mercade TM, Goyal L, Varkaris A, Palmieri LJ, Ikeda M, Kondo S, Bai LY, Ueno M, Chen LT, Papadopoulos KP, Shroff RT, Kizilbash SH, Hollebecque A, Adeva J, Cosman R, Yokota T, Park JO, Turk A, Liao CY, Satoh T, Borad MJ, El-Khoueiry A, Azad N, Jaeckle KA, Loong HH, Yong WP, Bender MH, Varughese SC, Sachdeva D, Radtke DB, Gueorguieva I, Szpurka AM, Chen HR, Liu H, Xu X, Rodon J.
Final Results from a First-in-Human Phase 1 Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations.
Clin Cancer Res. 2025 Sep 30. doi: 10.1158/1078-0432.CCR-25-0174. PMID: 41026608. Interventional study˰ ˍ

Mehta MP, Gondi V, Ahluwalia MS, Roberge D, Sio TTW, Trifiletti DM, Muanza T, Krpan AM, Zhu Z, Ramakrishna NR, Fiveash JB, Metellus P, Yu J, Wang CJ, Jacob J, Freyschlag CF, Csőszi T, Salmaggi A, Taliansky A, Lucas A, Debus J, Brown PD, Harat M; METIS study investigators.
Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study.
Int J Radiat Oncol Biol Phys. 2025 Sep 29:S0360-3016(25)06217-0. doi: 10.1016/j.ijrobp.2025.08.066. PMID: 41033612. Interventional study. ˍ